The state of New York currently has 30 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including New York, Rochester, Bronx and Buffalo.
A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS)
NCT05437276
Recruiting
PoNS therapy is a rehabilitation program that uses the PoNS device in conjunction with individualized physical exercise. This is an outcome research open label observational interventional multi-center study investigating the relationship between subject's adherence to PoNS therapy and therapeutic outcomes.
Gender:
All
Ages:
Between 22 years and 65 years
Trial Updated:
03/02/2023
Locations: NYU Langone Health, NYU Grossman School of Medicine, New York, New York
Conditions: Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)
Register for Updates
The Effect of Motor Imagery on Balance in Persons With Multiple Sclerosis
NCT05615207
Recruiting
This study will investigate if the use of motor imagery to practice a balance task is as effective as physically practicing balance tasks as measured by the Berg Balance Scale (BBS) in persons with MS. A secondary purpose is to investigate if using a motor imagery balance intervention will limit fatigue typically experienced with physical movement in this population.
Gender:
All
Ages:
All
Trial Updated:
02/03/2023
Locations: Dominican University New York, Orangeburg, New York
Conditions: Falls, Motor Imagery, Multiple Sclerosis, Balance, Fatigue
Register for Updates
High Intensity Interval Gait Training in Multiple Sclerosis
NCT05560880
Recruiting
Over 90% of persons with MS (pwMS) complain of difficulty with walking. High intensity interval gait training (HIIGT), where persons alternate brief periods of walking at high speeds with periods of rest has been found to improve walking in other neurologic diagnoses. However its impact on pwMS is not known. Most gait training in MS is done continuously at a slower pace. The purpose of this study is to compare the effects of HIIGT to traditional Moderate Intensity Continuous Gait Training (MICGT... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/05/2022
Locations: Hunter College, New York, New York
Conditions: Multiple Sclerosis
Register for Updates
Genes and Environment in Multiple Sclerosis
NCT01353547
Recruiting
The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfunction in immune cells, there are genetic alterations, environmental exposures and immunologic factors that make the development of MS more likely. Obtaining information about who is at risk for MS wil... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/16/2022
Locations: Columbia University Irving Center, New York, New York
Conditions: Multiple Sclerosis
Register for Updates
High Intensity Interval Gait Training in Multiple Sclerosis
NCT05529498
Recruiting
Over 90% of persons with MS (pwMS) complain of difficulty with walking. High intensity interval gait training (HIIGT), where persons alternate brief periods of walking at high speeds with periods of rest has been found to improve walking in other neurologic diagnoses. However its impact on pwMS is not known. Most gait training in MS is done continuously at a slower pace. The purpose of this study is to compare the effects of HIIGT to traditional Moderate Intensity Continuous Gait Training (MICGT... Read More
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
09/02/2022
Locations: Hunter College, New York, New York
Conditions: Multiple Sclerosis,Gait, Exercise
Register for Updates
A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets
NCT04550455
Recruiting
The purpose of this study is to explore the concept that biomarker sensitivity will detect activity in Multiple Sclerosis (MS) subjects and allow appropriate change in treatment to prevent dysfunction.
Gender:
All
Ages:
Between 21 years and 65 years
Trial Updated:
01/12/2022
Locations: Multiple Sclerosis Center of Northeastern New York, P.C., Latham, New York
Conditions: Multiple Sclerosis
Register for Updates